npj Parkinson's Disease (Oct 2024)

Direct and indirect regulation of β-glucocerebrosidase by the transcription factors USF2 and ONECUT2

  • Kathi Ging,
  • Lukas Frick,
  • Johannes Schlachetzki,
  • Andrea Armani,
  • Yanping Zhu,
  • Pierre-André Gilormini,
  • Ashutosh Dhingra,
  • Desirée Böck,
  • Ana Marques,
  • Matthew Deen,
  • Xi Chen,
  • Tetiana Serdiuk,
  • Chiara Trevisan,
  • Stefano Sellitto,
  • Claudio Pisano,
  • Christopher K. Glass,
  • Peter Heutink,
  • Jiang-An Yin,
  • David J. Vocadlo,
  • Adriano Aguzzi

DOI
https://doi.org/10.1038/s41531-024-00819-7
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Mutations in GBA1 encoding the lysosomal enzyme β-glucocerebrosidase (GCase) are among the most prevalent genetic susceptibility factors for Parkinson’s disease (PD), with 10–30% of carriers developing the disease. To identify genetic modifiers contributing to the incomplete penetrance, we examined the effect of 1634 human transcription factors (TFs) on GCase activity in lysates of an engineered human glioblastoma line homozygous for the pathogenic GBA1 L444P variant. Using an arrayed CRISPR activation library, we uncovered 11 TFs as regulators of GCase activity. Among these, activation of MITF and TFEC increased lysosomal GCase activity in live cells, while activation of ONECUT2 and USF2 decreased it. While MITF, TFEC, and USF2 affected GBA1 transcription, ONECUT2 might control GCase trafficking. The effects of MITF, TFEC, and USF2 on lysosomal GCase activity were reproducible in iPSC-derived neurons from PD patients. Our study provides a systematic approach to identifying modulators of GCase activity and deepens our understanding of the mechanisms regulating GCase.